Abstract
Neonatal hemochromatosis (NH) is a rare and severe liver disease of mainly intra-uterine onset, characterized by neonatal liver failure, hepatic and extrahepatic iron accumulation. This leads to an altered iron metabolism with resulting siderosis. The disease represents the most common cause of liver failure in neonates and is also the most common indication for neonatal liver transplantation. We present a case of a newborn diagnosed with NH and life threatening liver failure. Initial treatment consisted of chelation therapy and antioxidants, but lack of laboratory and clinical improvement led to an exchange transfusion followed by the singular substitution of intravenous immunoglobulin (IVIG). Both, exchange transfusion and IVIG were tolerated well and led to an improvement of the general condition of the patient and recovery of liver synthetic function. The subsequent favorable course of the disease is described in this case report.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cottier H, Vogt W . Über ein der Hämochromatose vergleichbares Krankheitsbild bei Neugeborenen. Schweiz Med Wochenschr 1957; 37: 39–43.
Murray KF, Kowdley KV . Neonatal hemochromatosis. Pediatrics 2001; 108 (4): 960–964.
Whitington PF . Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007; 27 (3): 243–250.
Whitington PF, Kelly S . Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008; 121 (6): e1615–e1621.
Timpani G, Foti F, Nicolo A, Nicotina PA, Nicastro E, Iorio R . Is exchange transfusion a possible treatment for neonatal hemochromatosis? J Hepatol 2007; 47 (5): 732–735.
Flynn DM, Mohan N, McKiernan P, Beath S, Buckels J, Mayer D et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003; 88 (2): F124–F127.
Rodrigues F, Kallas M, Nash R, Cheeseman P, D'Antiga L, Rela M et al. Neonatal hemochromatosis--medical treatment vs transplantation: the king's experience. Liver Transpl 2005; 11 (11): 1417–1424.
Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS . Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998; 26 (1): 85–89.
Escolano-Margarit MV, Miras-Baldo MJ, Parrilla-Roure M, Rivera-Cuello M, Narbona-Lopez E . Exchange transfusion as a possible therapy for neonatal hemochromatosis. J Pediatr Gastroenterol Nutr 2010; 50 (5): 566–568.
Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009; 155 (4): 566–571.
Grabhorn E, Richter A, Burdelski M, Rogiers X, Ganschow R . Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics 2006; 118 (5): 2060–2065.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Babor, F., Hadzik, B., Stannigel, H. et al. Successful management of neonatal hemochromatosis by exchange transfusion and immunoglobulin: a case report. J Perinatol 33, 83–85 (2013). https://doi.org/10.1038/jp.2012.9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.9